Purpose. Health related quality of life (HRQOL) in leukemia and lymphoma patients treated with high-dose chemotherapy followed by allogeneic (SCT) or autologous (ASCT) stem cell transplantation or receiving combination chemotherapy (CT) was prospectively assessed by the EORTC QLQ-C30 and compared with reference data from a general population sample. Material and methods. Forty-one leukemia patients (SCT group), 51 lymphoma patients (ASCT group) and 85 CT patients completed the EORTC QLQ-C30 at baseline and after one year. Results. The SCT group (median age 36) had better functioning scores and less symptomatology at baseline compared with the ASCT (median age 41) and CT groups (median age 37). Statistically significant differences Ͼ 10 on the 0-100 point scales were found with ten of 15 scales and items (p Ͻ.01) between the SCT and ASCT groups. Differences across groups were smaller after one year, with the only statistical significance being cognitive function (ASCT: 80 vs. CT: 89, p = .002). Before transplant, the SCT group had scores close to those in the general population but reported impaired role and social function (p Ͻ.0001) and more financial difficulties (p = .003). One year after transplant, the functional scores were still close to population values except lower social (p Ͻ.0001) and role function (p =.0004). More symptoms and problems were reported, especially appetite loss (p = .001) and financial difficulties ( p = .0001). The ASCT patients had significantly poorer results before transplant compared with the population on all scales and items ( p values = .0001 -.002), except pain. After one year, they still reported a less than optimal HRQOL relative to the population, with cognitive, physical, role and social function, dyspnoea, financial difficulties and global quality of life being most impaired (p Ͻ .001). Conclusion. One year after transplant, physical, role and social function were significantly impaired relative to other people. Comparison with population data yields important knowledge regarding the follow-up of medical and social consequences of intensive chemotherapy and aids in the information and counselling of patients. Prospective studies with extended follow-up periods are necessary to separate a slow recovery process from more permanently reduced HRQOL after transplant.
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Experience of a combined late effects clinic for patients who have undergone stem cell transplantation or intensive chemotherapy regimens (Abstract) H. Jessop, E. Vandenberghe, H. Davies, R. Ross, W. Ledger, M. Haggarty (Sheffield, UK) Background The Late Effects Clinic was set up at the Royal Hallamshire Hospital in Sheffield in 1997 with the aim of providing a structured multi-professional approach to follow up for patients who have undergone -Blood or marrow transplantation; Intensive chemotherapy / radiotherapy regimens during childhood for haematological malignancies or solid tumours; Intensive chemotherapy for acute leukaemia. Structure The clinic comprises a team of four Consultants, a Haematologist, an Endocrinologist, a Paediatrician with a special interest in Late Effects and a Professor of Obstetrics and Gynaecology who specialises in fertility preservation / intervention in patients who are undergoing chemotherapy. and two nurse specialists (endocrinology and haematology). Patients may see several members of the team during a clinic visit. Aims To monitor the endocrine, cardiac and lung function of this group of patients, thus detecting problems early and ensuring appropriate intervention / treatment. To assess the relevance of Bone Density in this group. To ensure effective re-immunisation of transplant patients and provide appropriate education. To ensure early detection and effective management of chronic GVH . To provide psychological support for patients with ongoing problems post treatment. Future Plans Audit of the effectiveness of the clinic Integration with a specialist cancer centre where adult patients with solid tumours are receiving similar intensive therapies. Provide an opportunity for research. Conclusion A successful clinic has been established where problems are identified early in a group of patients who have achieved long term disease free survival and who are offered the opportunity to experience the benefit of integrated care.
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